Clinical Trials Directory

Trials / Conditions / Psychotropic Drugs

Psychotropic Drugs

13 registered clinical trials studyying Psychotropic Drugs — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingAssociation Between Intake of Psychotropic Medications and Risk of Falls in Older Adults
NCT07112573
Ain Shams University—
RecruitingNebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting
NCT06752759
Theresa Jacob, PhD, MPHPhase 3
CompletedSEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY®
NCT05897398
Hospices Civils de Lyon—
RecruitingDrugs Experience for Adolescents With Anorexia
NCT06211517
Assistance Publique - Hôpitaux de Paris—
CompletedDecreasing Harms and Improving Child Health
NCT07392489
Glyn Jones-ElwynN/A
CompletedORiginal meThodology for Assessing the Impact of the Coronavirus Health Crisis on Psychotropic Drug Use
NCT05395897
Nantes University Hospital—
UnknownRemimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy
NCT05406102
First Affiliated Hospital Xi'an Jiaotong UniversityPhase 4
CompletedStudy to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
NCT05321602
Luye Pharma Group Ltd.Phase 1
CompletedRelative Bioavailability of LY03010 Compared to Listed Drug
NCT04922593
Luye Pharma Group Ltd.Phase 1
CompletedPharmacogenetics Anomaly Research in Children and Adolescents With Pharmacological Resistance to Psychotropic
NCT03114098
Fondation LenvalN/A
CompletedPilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
NCT01988311
Johns Hopkins UniversityPhase 1
RecruitingNational Pregnancy Registry for Psychiatric Medications
NCT01246765
Massachusetts General Hospital—
CompletedA Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)
NCT00294008
Janssen Korea, Ltd., Korea—